Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India
Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility. We reviewed rigorously maintained data of...
Gespeichert in:
Veröffentlicht in: | Diabetes & metabolic syndrome clinical research & reviews 2021-05, Vol.15 (3), p.1007-1008 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1008 |
---|---|
container_issue | 3 |
container_start_page | 1007 |
container_title | Diabetes & metabolic syndrome clinical research & reviews |
container_volume | 15 |
creator | Tyagi, Kanika Ghosh, Amerta Nair, Dipti Dutta, Koel Singh Bhandari, Prakash Ahmed Ansari, Irshad Misra, Anoop |
description | Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.
We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.
Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.
We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.
•Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19. |
doi_str_mv | 10.1016/j.dsx.2021.05.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8091733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1871402121001399</els_id><sourcerecordid>2528185748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</originalsourceid><addsrcrecordid>eNp9kc9uEzEQh1eIipbCA3BBPnJgt571_rOQkCAtEKmiF-BqTbzjrtONXexNSh-hb42TtFW5cLLl-ebn0XxZ9gZ4ARyak2XRxz9FyUsoeF1wDs-yI-jaLudCVM93d8irVD7MXsa45LyuZSlfZIdCSAkdr4-yu8-B8Goagl9fDmx28Wt-CpJZZ0hP1rvI0EwU2Aa1tg73T9axgXCcBo2BGLqe-WlI0I0PVxR2dWQ6RTqr2Y5ZUW81jsygtqOdbrfId7phpzQO9j2bu97iq-zA4Bjp9f15nP38cvZj9i0_v_g6n306z7VoGsixLcksSgSqdCeFNn0HVSl6KXrsSQgjOXJtgGppGpC8EWSAVxUXUlSLVovj7OM-93q9SHNpclPAUV0Hu8Jwqzxa9W_F2UFd-o3quIRWiBTw7j4g-N9ripNa2ahpHNGRX0dV1mUHXd1WXUJhj-rgYwxkHr8BrrYK1VIlhWqrUPFaJYWp5-3T-R47Hpwl4MMeoLSljaWgorbkdNpxSNZU7-1_4v8CMGOulw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528185748</pqid></control><display><type>article</type><title>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</title><source>Access via ScienceDirect (Elsevier)</source><creator>Tyagi, Kanika ; Ghosh, Amerta ; Nair, Dipti ; Dutta, Koel ; Singh Bhandari, Prakash ; Ahmed Ansari, Irshad ; Misra, Anoop</creator><creatorcontrib>Tyagi, Kanika ; Ghosh, Amerta ; Nair, Dipti ; Dutta, Koel ; Singh Bhandari, Prakash ; Ahmed Ansari, Irshad ; Misra, Anoop</creatorcontrib><description>Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.
We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.
Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.
We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.
•Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.</description><identifier>ISSN: 1871-4021</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2021.05.001</identifier><identifier>PMID: 33991805</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><ispartof>Diabetes & metabolic syndrome clinical research & reviews, 2021-05, Vol.15 (3), p.1007-1008</ispartof><rights>2021 Diabetes India</rights><rights>Copyright © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.</rights><rights>2021 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2021 Diabetes India</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</citedby><cites>FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dsx.2021.05.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33991805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tyagi, Kanika</creatorcontrib><creatorcontrib>Ghosh, Amerta</creatorcontrib><creatorcontrib>Nair, Dipti</creatorcontrib><creatorcontrib>Dutta, Koel</creatorcontrib><creatorcontrib>Singh Bhandari, Prakash</creatorcontrib><creatorcontrib>Ahmed Ansari, Irshad</creatorcontrib><creatorcontrib>Misra, Anoop</creatorcontrib><title>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</title><title>Diabetes & metabolic syndrome clinical research & reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.
We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.
Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.
We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.
•Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.</description><issn>1871-4021</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9uEzEQh1eIipbCA3BBPnJgt571_rOQkCAtEKmiF-BqTbzjrtONXexNSh-hb42TtFW5cLLl-ebn0XxZ9gZ4ARyak2XRxz9FyUsoeF1wDs-yI-jaLudCVM93d8irVD7MXsa45LyuZSlfZIdCSAkdr4-yu8-B8Goagl9fDmx28Wt-CpJZZ0hP1rvI0EwU2Aa1tg73T9axgXCcBo2BGLqe-WlI0I0PVxR2dWQ6RTqr2Y5ZUW81jsygtqOdbrfId7phpzQO9j2bu97iq-zA4Bjp9f15nP38cvZj9i0_v_g6n306z7VoGsixLcksSgSqdCeFNn0HVSl6KXrsSQgjOXJtgGppGpC8EWSAVxUXUlSLVovj7OM-93q9SHNpclPAUV0Hu8Jwqzxa9W_F2UFd-o3quIRWiBTw7j4g-N9ripNa2ahpHNGRX0dV1mUHXd1WXUJhj-rgYwxkHr8BrrYK1VIlhWqrUPFaJYWp5-3T-R47Hpwl4MMeoLSljaWgorbkdNpxSNZU7-1_4v8CMGOulw</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Tyagi, Kanika</creator><creator>Ghosh, Amerta</creator><creator>Nair, Dipti</creator><creator>Dutta, Koel</creator><creator>Singh Bhandari, Prakash</creator><creator>Ahmed Ansari, Irshad</creator><creator>Misra, Anoop</creator><general>Elsevier Ltd</general><general>Diabetes India. Published by Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210501</creationdate><title>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</title><author>Tyagi, Kanika ; Ghosh, Amerta ; Nair, Dipti ; Dutta, Koel ; Singh Bhandari, Prakash ; Ahmed Ansari, Irshad ; Misra, Anoop</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tyagi, Kanika</creatorcontrib><creatorcontrib>Ghosh, Amerta</creatorcontrib><creatorcontrib>Nair, Dipti</creatorcontrib><creatorcontrib>Dutta, Koel</creatorcontrib><creatorcontrib>Singh Bhandari, Prakash</creatorcontrib><creatorcontrib>Ahmed Ansari, Irshad</creatorcontrib><creatorcontrib>Misra, Anoop</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tyagi, Kanika</au><au>Ghosh, Amerta</au><au>Nair, Dipti</au><au>Dutta, Koel</au><au>Singh Bhandari, Prakash</au><au>Ahmed Ansari, Irshad</au><au>Misra, Anoop</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</atitle><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>15</volume><issue>3</issue><spage>1007</spage><epage>1008</epage><pages>1007-1008</pages><issn>1871-4021</issn><eissn>1878-0334</eissn><abstract>Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.
We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.
Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.
We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.
•Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33991805</pmid><doi>10.1016/j.dsx.2021.05.001</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1871-4021 |
ispartof | Diabetes & metabolic syndrome clinical research & reviews, 2021-05, Vol.15 (3), p.1007-1008 |
issn | 1871-4021 1878-0334 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8091733 |
source | Access via ScienceDirect (Elsevier) |
title | Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A43%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breakthrough%20COVID19%20infections%20after%20vaccinations%20in%20healthcare%20and%20other%20workers%20in%20a%20chronic%20care%20medical%20facility%20in%20New%20Delhi,%20India&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Tyagi,%20Kanika&rft.date=2021-05-01&rft.volume=15&rft.issue=3&rft.spage=1007&rft.epage=1008&rft.pages=1007-1008&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2021.05.001&rft_dat=%3Cproquest_pubme%3E2528185748%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528185748&rft_id=info:pmid/33991805&rft_els_id=S1871402121001399&rfr_iscdi=true |